1 Min Read
June 7 (Reuters) - Mallinckrodt Plc:
* Mallinckrodt enrolls first patient in phase 3 trial of Stratagraft® regenerative skin tissue Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.